Anti-human immunodeficiency virus-1 activity of MoMo30 protein isolated from the traditional African medicinal plant Momordica balsamina

[1]  V. Bond,et al.  Identification of a Novel Anti-HIV-1 Protein from Momordica balsamina Leaf Extract , 2022, International journal of environmental research and public health.

[2]  B. Höcker,et al.  The Stability Landscape of de novo TIM Barrels Explored by a Modular Design Approach , 2021, Journal of molecular biology.

[3]  L. Polito,et al.  Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases , 2019, Front. Pharmacol..

[4]  P. Rougé,et al.  Overview of the Structure–Function Relationships of Mannose-Specific Lectins from Plants, Algae and Fungi , 2019, International journal of molecular sciences.

[5]  T. Arndt.  Crystal , 2019, Springer Reference Medizin.

[6]  M. Puri,et al.  Purification and functional characterization of recombinant balsamin, a ribosome-inactivating protein from Momordica balsamina. , 2018, International journal of biological macromolecules.

[7]  J. C. Kouokam,et al.  Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections , 2018, BioMed research international.

[8]  Xiao-Ren Chen,et al.  The Plant Ribosome-Inactivating Proteins Play Important Roles in Defense against Pathogens and Insect Pest Attacks , 2018, Front. Plant Sci..

[9]  John R Yates,et al.  Global site-specific N-glycosylation analysis of HIV envelope glycoprotein , 2017, Nature Communications.

[10]  K. Ramessar,et al.  Antiviral lectins: Selective inhibitors of viral entry , 2017, Antiviral Research.

[11]  N. Dibal,et al.  Therapeutic effect of Momordica balsamina leaf extract on ethanol-induced gastric ulcer in Wistar rats , 2016 .

[12]  Graham Mills,et al.  An automated fitting procedure and software for dose-response curves with multiphasic features , 2015, Scientific Reports.

[13]  Y. Kapulnik,et al.  Plant derived substances with anti-cancer activity: from folklore to practice , 2015, Front. Plant Sci..

[14]  N. E. Thomford,et al.  Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition , 2015, Pharmaceuticals.

[15]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[16]  Pramod Kumar,et al.  Structural and functional evolution of chitinase‐like proteins from plants , 2015, Proteomics.

[17]  T. Ng,et al.  Lectins with Anti-HIV Activity: A Review , 2015, Molecules.

[18]  J. de Jong,et al.  Traditional health practitioners’ perceptions, herbal treatment and management of HIV and related opportunistic infections , 2014, Journal of Ethnobiology and Ethnomedicine.

[19]  M. Puri,et al.  Inhibition of HIV-1 Replication by Balsamin, a Ribosome Inactivating Protein of Momordica balsamina , 2013, PloS one.

[20]  Kathryn A. VandenBosch,et al.  Spatio-Temporal Expression Patterns of Arabidopsis thaliana and Medicago truncatula Defensin-Like Genes , 2013, PloS one.

[21]  S. S. Khadabadi,et al.  ANCIENT AND RECENT MEDICINAL USES OF CUCURBITACEAE FAMILY , 2013 .

[22]  V. Bond,et al.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. , 2011, AIDS research and human retroviruses.

[23]  M. Debnath,et al.  Momordica balsamina: a medicinal and neutraceutical plant for health care management. , 2009, Current pharmaceutical biotechnology.

[24]  C. Albrecht,et al.  A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). , 2008, Journal of ethnopharmacology.

[25]  Shibo Jiang,et al.  Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains , 2008, Proceedings of the National Academy of Sciences.

[26]  R. Pomerantz,et al.  Antiviral potentials of medicinal plants , 2007, Virus Research.

[27]  Shan Zhu,et al.  Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon , 2009, Molecular Biology Reports.

[28]  J. Balzarini.  Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? , 2007, Antiviral chemistry & chemotherapy.

[29]  J. Balzarini,et al.  Inhibition of HIV entry by carbohydrate-binding proteins. , 2006, Antiviral research.

[30]  M. Froeyen,et al.  Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120 , 2005, Journal of Biological Chemistry.

[31]  Riccardo Percudani,et al.  The anti‐HIV cyanovirin‐N domain is evolutionarily conserved and occurs as a protein module in eukaryotes , 2005, Proteins.

[32]  J. Grover,et al.  Pharmacological actions and potential uses of Momordica charantia: a review. , 2004, Journal of ethnopharmacology.

[33]  A. Sharma,et al.  Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat , 2004, Molecular and Cellular Biochemistry.

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[35]  M. Powell,et al.  Restoration of Wild-Type Infectivity to Human Immunodeficiency Virus Type 1 Strains Lacking nef by Intravirion Reverse Transcription , 2001, Journal of Virology.

[36]  R. Wierenga,et al.  The TIM‐barrel fold: a versatile framework for efficient enzymes , 2001, FEBS letters.

[37]  M Bycroft,et al.  The structure of a LysM domain from E. coli membrane-bound lytic murein transglycosylase D (MltD). , 2000, Journal of molecular biology.

[38]  G. Grant,et al.  Assessment of lectin inactivation by heat and digestion. , 1998, Methods in molecular medicine.

[39]  L K Pannell,et al.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development , 1997, Antimicrobial agents and chemotherapy.

[40]  S. Lee-Huang,et al.  Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Lee-Huang,et al.  Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. , 1995, Gene.

[42]  K. H. Kalk,et al.  Crystal structures of hevamine, a plant defence protein with chitinase and lysozyme activity, and its complex with an inhibitor. , 1994, Structure.

[43]  Z. Punja,et al.  Plant chitinases and their roles in resistance to fungal diseases. , 1993, Journal of nematology.

[44]  M. S. Manocha,et al.  Chitinases of fungi and plants: their involvement in morphogenesis and host‐parasite interaction , 1993 .

[45]  H. Yeung,et al.  beta-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells. , 1992, The International journal of biochemistry.

[46]  B Henrissat,et al.  A classification of glycosyl hydrolases based on amino acid sequence similarities. , 1991, The Biochemical journal.

[47]  M. Hood.  Comparison of four methods for measuring chitinase activity and the application of the 4-MUF assay in aquatic environments , 1991 .

[48]  S. Lee-Huang,et al.  MAP 30: a new inhibitor of HIV‐1 infection and replication , 1990, FEBS letters.

[49]  K. Tennekoon,et al.  Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. , 1990, Journal of ethnopharmacology.

[50]  D. Shah,et al.  Isolation and Characterization of the Genes Encoding Basic and Acidic Chitinase in Arabidopsis thaliana. , 1990, Plant physiology.

[51]  C. Jeffrey.  A review of the Cucurbitaceae , 1980 .

[52]  L. Barbieri,et al.  Toxicity ofMomordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes , 1980, Virchows Archiv. B, Cell pathology including molecular pathology.